Pfizer’s Blockbuster Migraine Portfolio Plan On Track With Zavzpret Approval

Second Product From $11.6bn Biohaven Acquisition

 
• By Mandy Jackson
Woman having headache, migraine. Cartoon vector illustration.
Zavzpret provided rapid pain and symptom relief in its Phase III trial • Source: Shutterstock

More from New Products

More from Scrip